Understanding autoimmune nodopathy: Case study of 57 year old's journey to recovery from ...
A 57-year-old man experienced severe, progressive pain, numbness, and tingling in his hands and feet since 2021, along with ...
pressat20 小时
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical ...
The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
ots21 小时
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical ...
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical ...
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...